The impact of postoperative radiotherapy on the survival of patients with stage III non-small cell lung cancer: A CONSORT-compliant analysis using the SEER database

Postoperative radiotherapy (PORT) is commonly used to treat patients with resected stage III non-small cell lung cancer (NSCLC), but its effectiveness remains uncertain. This retrospective cohort study aimed to investigate the impact of PORT on overall survival (OS) and evaluate its heterogeneity am...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Kun, Peng, Wang, Shuai, Zhifeng, Peng, Xin, Liu, Haibo, Zhang, Sanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
6800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270527/
https://www.ncbi.nlm.nih.gov/pubmed/37327271
http://dx.doi.org/10.1097/MD.0000000000034015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270527/
https://www.ncbi.nlm.nih.gov/pubmed/37327271
http://dx.doi.org/10.1097/MD.0000000000034015

Ejemplares similares